TABLE 4

Predicted M2 (i.e., clopidogrel active metabolite H4) exposure ratios in CYP2C19 PMs vs. EMs using static and dynamic models

Compared with the general situation schematized in Fig. 1, CYP2C19 was considered to be involved in the two metabolic steps to mimic the clopidogrel situation. With use of the static model, M2 exposure ratios were determined using the static model with eqs. 7 or 8 and using Simcyp as described under Materials and Methods. In the clopidogrel situation, FM, X, FM, Z, and FM, 2C19 represent CYP450-dependent pathways; FM, a and FM, b represent the undefined clearance (esterase for FM, a). Several studies have shown that Fm, a (esterase) is high compared with CYP450-dependent pathways at the first metabolic step and that Fm, b would be equivalent at the second metabolic step (Kazui et al., 2010; Gurbel et al., 2009). In the six simulations, Fm values were selected to mimic this situation. Data are arithmetic means (S.D.).

Fm ValuesStep 1Step 2M2 Exposure Ratios
Fm, aFM1, XFM1, 2C19FM, bFm2, ZFm2, 2C19Static ModelDynamic Model
Simulation 10.819 (0.0908)0.163 (0.0837)0.0175 (0.0173)0.515 (0.149)0.478 (0.150)0.00733 (0.00896)0.907 (0.0696)0.882 (0.0740)
Simulation 20.819 (0.0908)0.163 (0.0837)0.0175 (0.0173)0.513 (0.147)0.469 (0.151)0.0177 (0.0212)0.896 (0.0794)0.869 (0.0870)
Simulation 30.819 (0.0914)0.146 (0.757)0.0354 (0.0341)0.513 (0.147)0.469 (0.151)0.0177 (0.0212)0.816 (0.127)0.768 (0.127)
Simulation 40.819 (0.0914)0.146 (0.575)0.0354 (0.0341)0.511 (0.145)0.454 (0.152)0.0350 (0.0403)0.800 (0.139)0.751 (0.142)
Simulation 50.862 (0.0807)0.0761 (0.0433)0.0615 (0.0582)0.505 (0.143)0.388 (0.154)0.107 (0.105)0.554 (0.230)0.486 (0.198)
Simulation 60.827 (0.125)0.0203 (0.0125)0.152 (0.123)0.505 (0.149)0.306 (0.146)0.189 (0.154)0.162 (0.138)0.101 (0.0807)